Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
1005-36-1|n/a,n/a|1|42|shamexposed|0|becquerels initial or established lung burden|Inhalation|n/a|100 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan lung histopathology time to tumor occurrence|No information on individuals available for this study
1005-36-2|n/a,n/a|1|84|Pu-239 dioxide|480|becquerels initial or established lung burden|Inhalation|480±70 initial lung burden|140 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan lung histopathology time to tumor occurrence|No information on individuals available for this study
1005-36-3|n/a,n/a|1|42|NNP N-methyl N-nitrosamino butanone|0.3|micrograms per g animal|Injection, subcutaneously|3 w for 20 w|110 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan lung histopathology time to tumor occurrence|No information on individuals available for this study
1005-36-4|n/a,n/a|1|42|NNP N-methyl N-nitrosamino butanone|0.3|micrograms per g animal|Injection, subcutaneously|3 w for 20 w|150 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan lung histopathology time to tumor occurrence|No information on individuals available for this study
1005-36-4|n/a,n/a|2|84|Pu-239 dioxide|470|becquerels initial or established lung burden|Inhalation|470±68 initial lung burden|150 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan lung histopathology time to tumor occurrence|No information on individuals available for this study
1005-36-5|n/a,n/a|1|42|NNP N-methyl N-nitrosamino butanone|1|micrograms per g animal|Injection, subcutaneously|3 w for 20 w|80 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan lung histopathology time to tumor occurrence|No information on individuals available for this study
1005-36-6|n/a,n/a|1|42|NNP N-methyl N-nitrosamino butanone|1|micrograms per g animal|Injection, subcutaneously|3 w for 20 w|120 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan lung histopathology time to tumor occurrence|No information on individuals available for this study
1005-36-6|n/a,n/a|2|84|Pu-239 dioxide|460|becquerels initial or established lung burden|Inhalation|460±76 initial lung burden|120 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan lung histopathology time to tumor occurrence|No information on individuals available for this study
1005-36-7|n/a,n/a|1|42|NNP N-methyl N-nitrosamino butanone|50|micrograms per g animal|Injection, subcutaneously|3 w for 20 w|40 (0 in ERA)|Rat|Rat CDF (F344) /CrlBR|Male|Young Adult|Lifespan lung histopathology time to tumor occurrence|No information on individuals available for this study
